Michael Burry, the investor best known for his successful wager against the U.S. housing bubble, is once again taking a sharply contrarian stance. In Scion Asset Management’s latest 13F filing, the firm revealed a tightly concentrated portfolio worth about $44 million, with roughly 80% of its value tied to put options on Palantir Technologies and Nvidia. The filing presents a clear message: Burry appears to be positioning for a pullback in some of the market’s most celebrated artificial intelligence names.
A concentrated bet against AI momentum
The headline positions are difficult to ignore. Scion disclosed put exposure linked to 5 million Palantir shares and 1 million Nvidia shares, making those bearish options the dominant force inside the portfolio. In a compact book of this size, such concentration stands out as a high-conviction statement rather than a routine hedge.
The logic implied by the filing is consistent with Burry’s long-established style. He has often challenged consensus trades when valuations appear stretched, and the recent enthusiasm surrounding AI equities has created exactly the kind of crowded narrative that tends to attract his skepticism. The portfolio suggests Scion is not merely seeking protection from volatility, but actively expressing the view that euphoric pricing in AI-linked stocks could face a reality check.
That said, the position is directional and timing-sensitive. If enthusiasm around AI remains strong, and if large-cap beneficiaries continue to deliver robust earnings, put options can lose value quickly. But if earnings momentum slows or valuation concerns begin to matter more to the market, the payoff from such concentrated downside exposure could become substantial.
Not just defense: selective bullish exposure elsewhere
While the filing is dominated by the anti-AI trade, Scion did not build a portfolio defined only by caution. The firm also added call options on Pfizer and Halliburton, indicating a willingness to pursue upside in sectors that appear less crowded and more tied to cash flow, cyclicality, or clearer business drivers.
Pfizer represents exposure to large-cap pharmaceuticals, where established revenue streams and drug pipeline developments can support investor interest. Halliburton, meanwhile, gives Scion a way to participate in oilfield services, a segment that can benefit if drilling activity remains resilient or if energy capital spending strengthens. In both cases, the positions contrast sharply with the richly valued growth narrative surrounding AI leaders.
This mix suggests Burry is not simply turning broadly bearish on equities. Instead, he appears to be rotating away from segments he sees as overextended and toward industries where expectations may be more moderate and valuations less dependent on market excitement.
Equity picks point to U.S. consumer and healthcare resilience
On the cash equity side, Scion doubled its position in Lululemon Athletica and opened new stakes in SLM Corporation and Molina Healthcare. These holdings add another layer to the firm’s positioning.
Lululemon may reflect a targeted bet on selective consumer strength rather than broad market exposure. SLM brings in a credit and student-lending component, while Molina Healthcare introduces managed-care exposure tied to healthcare demand. Taken together, the three names suggest Scion is looking for relatively stable or durable revenue streams in the U.S. economy, even as it aggressively bets against one of the market’s most popular themes.
This approach fits a portfolio built around thesis-driven allocation rather than broad diversification. Instead of spreading capital across many sectors, Scion appears to be choosing a handful of specific ideas: short the most celebrated AI names, while remaining constructive on businesses tied to healthcare, energy services, and more selective parts of the domestic economy.
China exposure reduced as capital shifts to cleaner catalysts
Another notable element of the filing is what Scion exited. The firm liquidated prior holdings tied to Chinese e-commerce and also stepped away from U.S. health insurers. The article frames this as a move away from geopolitical complications, regulatory uncertainty, and policy-related overhangs.
In practical terms, the repositioning points to a preference for what investors often call “cleaner catalysts” — situations where the business case depends less on policy noise or external risk factors and more on fundamentals such as earnings, cash flow, and industry cycles. By reducing China-linked exposure and redirecting capital toward selected U.S. sectors, Scion appears to be narrowing its focus around opportunities it considers easier to underwrite.
Geographically, that means less exposure to China-related uncertainty and more emphasis on U.S.-based themes, from pharmaceutical majors to energy service firms and domestic consumer or healthcare names. This shift also aligns with a broader market trend in which some investors are looking beyond crowded AI trades in search of value elsewhere.
High conviction brings high risk
The structure of the portfolio matters as much as the individual positions. According to the filing, Scion now holds a small group of core equity positions and several options trades, with the options dominating the portfolio’s value. That setup makes the book highly sensitive to market direction and timing.
In other words, this is not a passive portfolio intended to track broad equity performance. It is a concentrated expression of opinion. If the thesis is right, the returns could be meaningful. If the market continues to reward AI leadership, however, the bearish core of the portfolio could come under pressure.
The article also notes an important caveat: Burry’s reputation was built on one of the most famous contrarian calls in financial history, but his post-crisis record has been mixed. Some of his prior macro and short-side bets, including positions against Tesla and broader indexes, were criticized for being early or failing to deliver on schedule. That history matters because in modern markets, timing can be just as important as direction.
The bigger takeaway for investors
For market watchers, Scion’s latest 13F offers less of a broad forecast and more of a precise map of where Burry sees asymmetry. He is skeptical where optimism is loudest, especially in AI-linked equities commanding premium valuations. At the same time, he remains willing to deploy capital into companies and sectors where cash flows, cyclicality, or domestic resilience provide a more grounded fundamental case.
Whether the anti-AI bet proves correct will depend on what happens next with earnings, sentiment, and institutional flows. Nvidia and Palantir remain deeply embedded in one of the strongest market narratives of recent years, and narrative strength can keep valuations elevated longer than many contrarians expect. Still, the filing leaves little doubt about Scion’s current posture: bearish on the hottest AI trade, selective and opportunistic elsewhere, and fully comfortable making visible, concentrated bets when valuation and sentiment appear out of balance.
For investors tracking positioning rather than commentary, that may be the most important message. Burry is not trying to own the market. He is attempting to identify where consensus may be most vulnerable — and then placing a portfolio around that conviction.